Blood:缺铁促进巨核系-红系祖细胞(MEP)向巨核细胞系偏倚进展

2019-08-28 MedSci MedSci原创

缺铁性贫血患者血小板增多的机制尚不清楚。有这样一种假设,即低铁会促进巨核系-红系祖细胞(MEP)向巨核细胞(Mk)系偏倚进展。Xavier-Ferrucio等人在人和小鼠中证实了该假设。与野生型(WT)小鼠的MEP相比,在表现为缺铁性贫血和血小板增多症的特异性敲除跨膜丝氨酸蛋白酶6(Tmprss6-/-)小鼠的MEP中,研究人员观察到Mk偏倚、不稳定铁减少和增殖减少。骨髓移植实验显示是系统性铁缺乏

缺铁性贫血患者血小板增多的机制尚不清楚。有这样一种假设,即低铁会促进巨核系-红系祖细胞(MEP)向巨核细胞(Mk)系偏倚进展。Xavier-Ferrucio等人在人和小鼠中证实了该假设。

与野生型(WT)小鼠的MEP相比,在表现为缺铁性贫血和血小板增多症的特异性敲除跨膜丝氨酸蛋白酶6(Tmprss6-/-)小鼠的MEP中,研究人员观察到Mk偏倚、不稳定铁减少和增殖减少。骨髓移植实验显示是系统性铁缺乏(而非造血细胞Tmprss6敲除的局部作用)导致了在Tmprss6-/-小鼠中所观察到的MEP谱系分化偏倚。获得性缺铁性贫血的非转基因小鼠也表现为血小板增多和Mk偏倚性MEP。

基因表达分析显示,与WT MEP相比,在Tmprss6-/- MEP中,编码代谢、VEGF和ERK通路相关基因的mRNA富集表达。敲低转铁蛋白受体2后,人类原代MEP也表现出增殖减少和Mk偏倚分化,与缺铁性贫血小鼠模型中的表现一致。信号转导分析表明,缺铁时,人和小鼠MEP的磷酸化-ERK1/2水平均低于对照组。

本研究结果与另一个小鼠模型(骨髓环境低铁,影响MEP代谢、减弱ERK信号、减缓增殖,并使MEP向Mk细胞系偏倚分化)的结果一致。

原始出处:

Juliana Xavier-Ferrucio, et al.Low Iron Promotes Megakaryocytic Commitment of Megakaryocytic-Erythroid Progenitors in Humans and Mice.Blood 2019 :blood.2019002039; doi: https://doi.org/10.1182/blood.2019002039

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1395174, encodeId=53c613951e443, content=<a href='/topic/show?id=c268e940840' target=_blank style='color:#2F92EE;'>#缺铁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79408, encryptionId=c268e940840, topicName=缺铁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490277, encodeId=1cc414902e7dd, content=<a href='/topic/show?id=af9f48201a9' target=_blank style='color:#2F92EE;'>#巨核细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48201, encryptionId=af9f48201a9, topicName=巨核细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d78715376, createdName=liuquan, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512474, encodeId=7d6a15124e47d, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554023, encodeId=34d9155402320, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1395174, encodeId=53c613951e443, content=<a href='/topic/show?id=c268e940840' target=_blank style='color:#2F92EE;'>#缺铁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79408, encryptionId=c268e940840, topicName=缺铁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490277, encodeId=1cc414902e7dd, content=<a href='/topic/show?id=af9f48201a9' target=_blank style='color:#2F92EE;'>#巨核细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48201, encryptionId=af9f48201a9, topicName=巨核细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d78715376, createdName=liuquan, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512474, encodeId=7d6a15124e47d, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554023, encodeId=34d9155402320, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1395174, encodeId=53c613951e443, content=<a href='/topic/show?id=c268e940840' target=_blank style='color:#2F92EE;'>#缺铁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79408, encryptionId=c268e940840, topicName=缺铁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490277, encodeId=1cc414902e7dd, content=<a href='/topic/show?id=af9f48201a9' target=_blank style='color:#2F92EE;'>#巨核细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48201, encryptionId=af9f48201a9, topicName=巨核细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d78715376, createdName=liuquan, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512474, encodeId=7d6a15124e47d, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554023, encodeId=34d9155402320, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1395174, encodeId=53c613951e443, content=<a href='/topic/show?id=c268e940840' target=_blank style='color:#2F92EE;'>#缺铁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79408, encryptionId=c268e940840, topicName=缺铁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490277, encodeId=1cc414902e7dd, content=<a href='/topic/show?id=af9f48201a9' target=_blank style='color:#2F92EE;'>#巨核细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48201, encryptionId=af9f48201a9, topicName=巨核细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d78715376, createdName=liuquan, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512474, encodeId=7d6a15124e47d, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554023, encodeId=34d9155402320, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Aug 30 11:20:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]

相关资讯

小细胞低色素性贫血,一表分清四种病因

患者男性,15岁,诉“乏力、面色苍白1个月”。1个月前开始感到劳累后疲乏无力、心慌,伴面色苍白,但未到医院就诊。2周前因呕吐、腹泻到当地医院就诊,查血常规示

JAMA:口服铁补充剂能改善心衰合并缺铁患者的运动能力?

2017年5月,发表在《JAMA》的一项由美国科学家进行的IRONOUT HF随机临床试验,发现口服铁补充剂对心衰合并射血分数降低和缺铁患者的运动能力无改善。

Lancet Haematology:缺铁女性如何补铁效果佳?不妨试试这些给药方案

2017年发表在《Lancet Haematol》的两项开放性、随机对照试验,比较了缺铁女性中,早晨单剂量法vs每日两次剂量连续vs隔日口服补铁的效果。

Science:难以置信!美国发现神奇小分子,开启缺铁相关疾病治疗新方向!

80、90那一代,很多人都是喝着哈药集团的各种补充钙、铁、锌的口服液长大的。这些金属元素对人体的重要性想必不需要我们再强调。

Cell:缺血就要补铁吗?答案是错的!华人学者揭示大肠杆菌是关键!

科罗拉多大学韩珉教授课题组今天在《Cell》发表最新文章,揭示了作为广为人知的致病细菌(如食物中毒、窃取宿主营养物),大肠杆菌实际上可以通过生产一种帮助细胞摄取铁的化合物对人类健康起关键作用。

Circulation:心衰患者贫血与缺铁,现有概念与新兴疗法

贫血和缺铁是重要且常见的合并症,在心衰患者中常常同时存在。这两种症状同时或单独存在均与较差的临床状态和更差的结局相关。贫血和缺铁只是心衰严重度的指标?它们是否影响心衰进展和结局并因此需要进行治疗?目前仍不清楚。2018年7月,发表在《Circulation》的一项由美国学者进行的综述,探讨了心衰患者贫血与缺铁的原因和治疗方案的选择。